Annual EBITDA
-$28.41 M
+$30.27 M+51.59%
December 1, 2023
Summary
- As of February 8, 2025, ARTV annual EBITDA is -$28.41 million, with the most recent change of +$30.27 million (+51.59%) on December 1, 2023.
- During the last 3 years, ARTV annual EBITDA has fallen by -$10.69 million (-60.31%).
- ARTV annual EBITDA is now -60.31% below its all-time high of -$17.72 million, reached on December 1, 2020.
Performance
ARTV EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$17.71 M
-$2.12 M-13.61%
September 1, 2024
Summary
- As of February 8, 2025, ARTV quarterly EBITDA is -$17.71 million, with the most recent change of -$2.12 million (-13.61%) on September 1, 2024.
- Over the past year, ARTV quarterly EBITDA has dropped by -$29.07 million (-255.78%).
- ARTV quarterly EBITDA is now -255.78% below its all-time high of $11.37 million, reached on September 1, 2023.
Performance
ARTV Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$58.58 M
-$29.07 M-98.56%
September 1, 2024
Summary
- As of February 8, 2025, ARTV TTM EBITDA is -$58.58 million, with the most recent change of -$29.07 million (-98.56%) on September 1, 2024.
- Over the past year, ARTV TTM EBITDA has dropped by -$38.05 million (-185.37%).
- ARTV TTM EBITDA is now -891.30% below its all-time high of -$5.91 million, reached on December 1, 2020.
Performance
ARTV TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ARTV EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.6% | -255.8% | -185.4% |
| 3 y3 years | -60.3% | -19.8% | -83.7% |
| 5 y5 years | - | -19.8% | -83.7% |
ARTV EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +60.3% | -255.8% | at low | -242.3% | at low |
| 5 y | 5-year | -60.3% | +60.3% | -255.8% | +26.6% | -891.3% | at low |
| alltime | all time | -60.3% | +60.3% | -255.8% | +26.6% | -891.3% | at low |
Artiva Biotherapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.71 M(+13.6%) | -$58.58 M(+98.6%) |
| Jun 2024 | - | -$15.59 M(+12.1%) | -$29.50 M(+2.8%) |
| Mar 2024 | - | -$13.90 M(+22.2%) | -$28.70 M(-10.0%) |
| Dec 2023 | -$28.41 M | -$11.38 M(-200.1%) | -$31.90 M(+55.4%) |
| Sep 2023 | - | $11.37 M(-176.9%) | -$20.53 M(-35.6%) |
| Jun 2023 | - | -$14.78 M(-13.6%) | -$31.89 M(+86.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$17.11 M(+43.1%) | -$17.11 M(-26.3%) |
| Dec 2022 | -$58.67 M(-18.0%) | - | - |
| Mar 2022 | - | -$11.96 M(+6.3%) | -$23.21 M(-34.4%) |
| Dec 2021 | -$71.58 M(+304.0%) | -$11.25 M(-53.4%) | -$35.39 M(+17.8%) |
| Mar 2021 | - | -$24.14 M(+308.5%) | -$30.05 M(+408.5%) |
| Dec 2020 | -$17.72 M | -$5.91 M | -$5.91 M |
FAQ
- What is Artiva Biotherapeutics annual EBITDA?
- What is the all time high annual EBITDA for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics annual EBITDA year-on-year change?
- What is Artiva Biotherapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics quarterly EBITDA year-on-year change?
- What is Artiva Biotherapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Artiva Biotherapeutics?
- What is Artiva Biotherapeutics TTM EBITDA year-on-year change?
What is Artiva Biotherapeutics annual EBITDA?
The current annual EBITDA of ARTV is -$28.41 M
What is the all time high annual EBITDA for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high annual EBITDA is -$17.72 M
What is Artiva Biotherapeutics annual EBITDA year-on-year change?
Over the past year, ARTV annual EBITDA has changed by +$30.27 M (+51.59%)
What is Artiva Biotherapeutics quarterly EBITDA?
The current quarterly EBITDA of ARTV is -$17.71 M
What is the all time high quarterly EBITDA for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high quarterly EBITDA is $11.37 M
What is Artiva Biotherapeutics quarterly EBITDA year-on-year change?
Over the past year, ARTV quarterly EBITDA has changed by -$29.07 M (-255.78%)
What is Artiva Biotherapeutics TTM EBITDA?
The current TTM EBITDA of ARTV is -$58.58 M
What is the all time high TTM EBITDA for Artiva Biotherapeutics?
Artiva Biotherapeutics all-time high TTM EBITDA is -$5.91 M
What is Artiva Biotherapeutics TTM EBITDA year-on-year change?
Over the past year, ARTV TTM EBITDA has changed by -$38.05 M (-185.37%)